Skip to content

Premedication Simethione Improves Visibility During Bowel Cleansing for Colonoscopy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02540239
Enrollment
590
Registered
2015-09-03
Start date
2015-01-31
Completion date
2016-04-30
Last updated
2016-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bowel Preparation Scale, the Amount of Air Bubble, Adenoma Detection Rate

Brief summary

To evaluate the efficacy, visibility of low volume polyethyleneglycol-simeticone (2-LPEG-S) for colonoscopy.

Detailed description

In this randomized controlled study, consecutive outpatients scheduled for elective colonoscopy were randomized into two groups. Group A patients (n = 300) used only 2 L PEG before colonoscopy. Patients in group B (n = 300) were additionally advised to simeticone plus 2 L PEG, The overall quality of colonoscopy cleaning was evaluated using the Boston Bowel Preparation Scale by a single endoscopist who was blinded to the intervention. Visibility was blindly assessed for the amount of air bubbles and adenoma detection rate (ADR). Difficulty of procedure, and adverse events were also evaluated.

Interventions

DRUG2L PEG
DRUG2L PEG+simethicone

Sponsors

First Affiliated Hospital of Zhejiang University
CollaboratorOTHER
Sir Run Run Shaw Hospital
CollaboratorOTHER
Tongji Hospital
CollaboratorOTHER
Qilu Hospital of Shandong University
CollaboratorOTHER
Zhongda Hospital
CollaboratorOTHER
Jinan Military General Hospital
CollaboratorOTHER
First Hospital of China Medical University
CollaboratorOTHER
Changhai Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SCREENING
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients are between 18-65 years old * undergoing colonoscopy for diagnostic investigation, colorectal cancer screening or follow-up

Exclusion criteria

* suspected gastrointestinal obstruction or perforation * severe acute inflammatory bowel disease * toxic megacolon * ileus or gastric retention, ileostomy, * hypersensitivity to any of the ingredients * pregnancy and lactation and/or at a risk of becoming pregnant

Design outcomes

Primary

MeasureTime frameDescription
adenoma detection rate2 days
bowel preparation scale2 days
the amount of air bubbles2 daysFive areas of the colon (rectosigmoid, descending, transverse, ascending, and cecum) were graded for the amount of air bubbles.The amount of intraluminal air bubbles was classified into four grades as shown below: Grade 0 = No or minimal scattered bubbles; Grade 1 = Bubbles covering at least half the luminal diameter; Grade 2 = Bubbles covering the circumference of the lumen; Grade 3 = Bubbles filling the entire lumen.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026